It was reported that there was an issue with the product gk970r - caspar bipolar forceps 1.0x125/220mm.According to the complaint description, electrocoagulation bipolar adhesion was severe and hemostasis was difficult.This resulted in cerebrospinal fluid (csf) leakage repair, performed under general anesthesia.The patient had been undergoing transnasal sellar space occupying resection under general anesthesia with neuroendoscope.Snake brand bipolar coagulator forceps were used during the operation.The patient was then discharged with improved condition.An additional medical intervention was required.According to manufacturer's reporting evaluation in accordance with 21 cfr 803, section 803.3, this event is considered reportable for the following reason: - serious injury (report not later than 30 days).The assessment for the reportability of this adverse event was based on patient harm, additional medical intervention.Further details were not provided.The adverse event is filed under aesculap ag reference no.(b)(4).
|
Investigation results: the product was not available for investigation, and pictures also were not provided.The investigation results were based on analysis of production records and historical data review.Batch history review: the device quality and manufacturing history records have been checked for all available lot numbers and the products were found to be according to our specification valid at the time of production.There are no other similar complaints within this batch.According to manufacturer's reporting evaluation in accordance with 21 cfr 803, section 803.3, this event is considered reportable for the following reason: - serious injury (report not later than 30 days).The assessment for the reportability of this adverse event was based on patient harm, additional medical intervention.Conclusion/preventive measures: without the product, a clear root cause conclusion cannot be drawn.There is no indication for a material-, manufacturing- or design-related failure.In the event that the complaint product will be provided for investigation in the future, an update of this report will be provided unsolicited.Based upon the investigation results, a capa is not necessary.
|